SLC5A2 and Hypomagnesemia: Moreover, SGLT2 inhibitors rarely cause diuresis-related electrolyte abnormalities, such as hypokalaemia, hypomagnesemia, and hyperuricemia, suggesting that SGLT2 inhibitors lower BP by other methods in addition to “diuresis,” which may be secondary to reduced arterial stiffness and improved endothelial function.